Akèy › Sakom Ewing › Massachusetts › Boston
Etid klinik pou Sakom Ewing nan Boston, MA
6 etid pou Sakom Ewing ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
Ap rekriteFaz 1
- Dana Farber Cancer Institute, Boston
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Ap rekriteFaz 1/2
- Dana-Farber Cancer Institute ( Site 1013), Boston
Lurbinectedin in FET-Fused Tumors
Ap rekriteFaz 1/2
- Dana-Farber Cancer Institute, Boston
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Ap rekriteFaz 1/2
- Dana-Farber Cancer Institute, Boston
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Ap rekriteFaz 1
- Mass General Brigham Cancer Institute, Boston
- Dana Farber Cancer Institute, Boston
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Ap rekriteFaz 1/2
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
Etid Sakom Ewing nan lòt vil
- New York City, NY8 etid
- Houston, TX7 etid
- Philadelphia, PA7 etid
- Memphis, TN7 etid
- Los Angeles, CA6 etid
- Aurora, CO6 etid
- Washington, DC6 etid
- Birmingham, AL5 etid
- Atlanta, GA5 etid
- Gainesville, FL4 etid
- Phoenix, AZ4 etid
- Salt Lake City, UT4 etid
Lòt etid nan Boston
- Kansè nan tete110 etid
- Kansè Poumon ki pa ti selil89 etid
- Kansè (tout kalite)86 etid
- Kansè kolorektal63 etid
- Kansè Metastatik63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat60 etid
- Depresyon51 etid
- Kansè Endomèt50 etid
- Leksemi mieloïd egi45 etid
- Kansè pankreyas44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.